Alpha Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Alpha Capital Management's GILD Position: Q1 2024 in Review
Alpha Capital Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 45,624 shares — an estimated $3.7M sold.
Alpha Capital Management first reported a position in GILD in Q4 2016 and held it in 19 quarters. The position peaked at $3.7M in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Alpha Capital Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Alpha Capital Management sold 45,624 Gilead Sciences shares in Q1 2024, an estimated $3.7M.
- Alpha Capital Management first reported a position in Gilead Sciences in Q4 2016 and held it in 19 quarters.
- Alpha Capital Management's Gilead Sciences position peaked at $3.7M in Q4 2023.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Alpha Capital Management's 13F filing for Q1 2024, filed 12 Apr 2024.